<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00461656</url>
  </required_header>
  <id_info>
    <org_study_id>ABR 14357</org_study_id>
    <nct_id>NCT00461656</nct_id>
  </id_info>
  <brief_title>Povidone-iodine Antisepsis for Strabismus Surgery</brief_title>
  <acronym>PASS</acronym>
  <official_title>Prospective, Randomized, Double-blind Comparison of 5 % Against 1.25 % Povidone-iodine Solution as Preoperative Antisepsis for Strabismus Surgery in Young Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Free University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rotterdam Eye Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laurentius Hospital Roermond</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Martin-Luther-Universit√§t Halle-Wittenberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Erasmus Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the efficacy of 5 % vs. 1.25 % povidone-iodine (PI)
      as preoperative antiseptic prior to strabismus surgery in children as a prophylaxis of
      endophthalmitis. Given the low rate of endophthalmitis the conjunctival bacterial flora rate
      is used as surrogate marker to determine the effectiveness of topical PI in reducing or
      eliminating bacteria from the ocular surface at the time of the surgery. Secondary objective
      is a reduction of the incidence of postoperative endophthalmitis after strabismus surgery in
      young children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Endophthalmitis after strabismus surgery in young children leads to blindness and
      loss of the affected eye. It is caused by conjunctival bacteria. PI solutions between 1% and
      5% reduce the number of bacteria on the conjunctiva. The concentration used varies widely
      among clinics, from 1% to 5%. In vitro studies have shown that PI is paradoxically more
      effective at lower concentration, but in cataract surgery in elderly, 1% PI has been shown to
      be less effective than 5% PI. Dilution by tear fluid or binding of PI to proteins in tear
      fluid may lower its effectiveness. Since endophthalmitis after strabismus surgery especially
      affects young children and the bacterial flora of the conjunctiva in children is different
      from that in adults, the cataract PI study should be repeated in young children operated for
      strabismus.

      Objective: To compare the efficacy of 5 % vs. 1.25 % povidone-iodine (PI) as preoperative
      antiseptic prior to strabismus surgery in children as a prophylaxis of endophthalmitis. Given
      the low rate of endophthalmitis the conjunctival bacterial flora rate is used as surrogate
      marker to determine the effectiveness of topical PI in reducing or eliminating bacteria from
      the ocular surface at the time of the surgery.

      Design: The study is a multi-centre, prospective, randomized-controlled, parallel-groups,
      assessor-blind (microbiological assessments), investigator-initiated trial.

      Study population: All children under 6 years of age attending the 15 participating clinics
      for routine strabismus surgery will be eligible for the study at the point that a strabismus
      operation is planned. The clinics (5 Dutch, 10 German) will each recruit approximately 20
      patients. The minimum sample size is 2 x 100 patients.

      Intervention: Diluted PI, 1.25% or 5%, will be prepared in a sterile fashion, and distributed
      in single-use dispensers. These will be coded for randomization. Before initiation of
      surgery, children randomized to the 5% PI group will have their conjunctival fornices
      irrigated with 5 ml PI 5%. Children randomized to the 1.25% PI group will have their
      conjunctival fornices irrigated with 5 ml PI 1.25%. Conjunctiva cultures for aerobic and
      anaerobic bacteria will be obtained (1) after general anesthesia has been established, (2)
      5-10 min after PI irrigation, (3) after reattachment of the eye muscles and (4) after closing
      the conjunctiva with sutures.

      Primary outcome: The difference in the mean numbers of bacterial colony forming units (CFUs)
      from pre-irrigation (l) to post-irrigation with PI (2-4).

      Secondary outcome: Iodine excretion after surgery, assessed as urine iodine concentration per
      creatinine clearance.

      Postoperative erosion of the cornea and corneal oedema. Both of these have been described as
      side-effects of PI use.

      Nature and extent of the burden and risks associated with participation:

      Risks are limited to the act of taking the four bacterial cultures, as both 1.25% PI and 5%
      PI are approved preoperative antiseptic applications of PI and both are used, rather
      indiscriminately, by the university departments of ophthalmology participating in the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The difference in the mean numbers of bacterial colony forming units from pre-irrigation to post-irrigation with PI.</measure>
    <time_frame>Cultures taken during surgery, evaluated within 2 days postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Iodine excretion after surgery, assessed as urine iodine concentration per creatinine clearance.</measure>
    <time_frame>24 hours postoperatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative erosion of the cornea and corneal oedema.</measure>
    <time_frame>within 24 hours postoperatively</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">70</enrollment>
  <condition>Strabismus</condition>
  <condition>Surgery</condition>
  <condition>Endophthalmitis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Preoperative conjunctival irrigation with 5% or 1.25% PI</intervention_name>
    <description>Before initiation of surgery, children will have their conjunctival fornices irrigated with 5 ml PI 5% or with 5 ml PI 1.25%</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Children attending for routine strabismus surgery are eligible for the study. Criteria for
        inclusion:

          1. Children &lt; 6 years of age

          2. undergoing surgery for strabismus for the first time, including any recession and/or
             resection surgery of the medial and/or lateral rectus muscles.

          3. willing to take part in all aspects of the study with written informed consent on the
             study participation of the child provided by the parents.

        Exclusion Criteria:

          1. Any history or current condition of hypersensitivity to iodine

          2. Children on topical antibiotic within the last 30 days

          3. Children with signs of acute conjunctivitis, blepharitis, dacryocystitis or
             respiratory infection within the last 30 days

          4. Children with asthma or similar chronic, obstructive pulmonary disorder

          5. Insufficiently treated amblyopia, i.e. a difference between the visual acuities of
             both eyes larger than 1 LogMARline.

          6. Neurological or psychiatric disorder, medication, other eye disorder, decreased visual
             acuity caused by brain damage or trauma.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huibert J Simonsz, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Erasmus Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Herminia Mi√±o de Kaspar, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universit√§ts-Augenklinik Ludwig-Maximilian University Munich Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ernst Moritz Arndt University</name>
      <address>
        <city>Greifswald</city>
        <zip>D-17487</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universit√§ts-Augenklinik</name>
      <address>
        <city>Magdeburg</city>
        <zip>D-39120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universit√§ts-Augenklinik Ludwig-Maximilian University</name>
      <address>
        <city>Munich</city>
        <zip>D-80336</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept. Ophthalmology Free University Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>NL-1007MB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept. Ophthalmology Academical Medical Center</name>
      <address>
        <city>Amsterdam</city>
        <zip>NL-1105AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept. Ophthalmology</name>
      <address>
        <city>Leiden</city>
        <zip>NL-2300RC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept. of Ophthalmology St. Laurentius Ziekenhuis</name>
      <address>
        <city>Roermond</city>
        <zip>NL-6040AX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rotterdam Eye Hospital</name>
      <address>
        <city>Rotterdam</city>
        <zip>3011BH</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dept. of Ophthalmology Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <zip>NL3000CA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Anderson RL, Vess RW, Carr JH, Bond WW, Panlilio AL, Favero MS. Investigations of intrinsic Pseudomonas cepacia contamination in commercially manufactured povidone-iodine. Infect Control Hosp Epidemiol. 1991 May;12(5):297-302.</citation>
    <PMID>1865100</PMID>
  </reference>
  <reference>
    <citation>Apt L, Isenberg S, Yoshimori R, Paez JH. Chemical preparation of the eye in ophthalmic surgery. III. Effect of povidone-iodine on the conjunctiva. Arch Ophthalmol. 1984 May;102(5):728-9.</citation>
    <PMID>6721765</PMID>
  </reference>
  <reference>
    <citation>Bannerman TL, Rhoden DL, McAllister SK, Miller JM, Wilson LA. The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol. 1997 Mar;115(3):357-61.</citation>
    <PMID>9076208</PMID>
  </reference>
  <reference>
    <citation>Berkelman RL, Holland BW, Anderson RL. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol. 1982 Apr;15(4):635-9.</citation>
    <PMID>7040461</PMID>
  </reference>
  <reference>
    <citation>Binder CA, Mi√±o de Kaspar H, Klauss V, Kampik A. [Preoperative infection prophylaxis with 1% polyvidon-iodine solution based on the example of conjunctival staphylococci]. Ophthalmologe. 1999 Oct;96(10):663-7. German.</citation>
    <PMID>10552160</PMID>
  </reference>
  <reference>
    <citation>Caldwell DR, Kastl PR, Cook J, Simon J. Povidone-iodine: its efficacy as a preoperative conjunctival and periocular preparation. Ann Ophthalmol. 1984 Jun;16(6):577, 580.</citation>
    <PMID>6611102</PMID>
  </reference>
  <reference>
    <citation>Carothers TS, Coats DK, McCreery KM, Rossman SN, Wilson P, Wu TG, Paysse EA. Quantification of incidental needle and suture contamination during strabismus surgery. Binocul Vis Strabismus Q. 2003;18(2):75-9.</citation>
    <PMID>12765540</PMID>
  </reference>
  <reference>
    <citation>Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002 Jan;109(1):13-24. Review.</citation>
    <PMID>11772573</PMID>
  </reference>
  <reference>
    <citation>Davis GH, Finlayson N, Kemp R. Dilution of povidone-iodine. Med J Aust. 1985 Sep 30;143(7):321.</citation>
    <PMID>4046931</PMID>
  </reference>
  <reference>
    <citation>Dereklis DL, Bufidis TA, Tsiakiri EP, Palassopoulos SI. Preoperative ocular disinfection by the use of povidone-iodine 5%. Acta Ophthalmol (Copenh). 1994 Oct;72(5):627-30.</citation>
    <PMID>7887164</PMID>
  </reference>
  <reference>
    <citation>Ferguson AW, Scott JA, McGavigan J, Elton RA, McLean J, Schmidt U, Kelkar R, Dhillon B. Comparison of 5% povidone-iodine solution against 1% povidone-iodine solution in preoperative cataract surgery antisepsis: a prospective randomised double blind study. Br J Ophthalmol. 2003 Feb;87(2):163-7.</citation>
    <PMID>12543744</PMID>
  </reference>
  <reference>
    <citation>Grimes SR, Hollsten D, Nauschuetz WF, Whiddon RG, Trevino SB. Effect of povidone-iodine irrigation on the preoperative chemical preparation of the eye. Mil Med. 1992 Mar;157(3):111-3.</citation>
    <PMID>1603399</PMID>
  </reference>
  <reference>
    <citation>Katosova LK. [The features of Haemophilus influenza and Streptococcus pneumoniae carriage and the comparative characteristics of strains isolated from healthy children and from patients with acute and chronic respiratory infections]. Zh Mikrobiol Epidemiol Immunobiol. 1994 Aug-Sep;Suppl 1:55-60. Russian.</citation>
    <PMID>7856352</PMID>
  </reference>
  <reference>
    <citation>Khashu M, Chessex P, Chanoine JP. Iodine overload and severe hypothyroidism in a premature neonate. J Pediatr Surg. 2005 Feb;40(2):E1-4.</citation>
    <PMID>15750908</PMID>
  </reference>
  <reference>
    <citation>Lacey RW, Catto A. Action of povidone-iodine against methicillin-sensitive and -resistant cultures of Staphylococcus aureus. Postgrad Med J. 1993;69 Suppl 3:S78-83.</citation>
    <PMID>8290463</PMID>
  </reference>
  <reference>
    <citation>Mi√±o de Kaspar H, Chang RT, Singh K, Egbert PR, Blumenkranz MS, Ta CN. Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery. Arch Ophthalmol. 2005 Feb;123(2):161-5.</citation>
    <PMID>15710810</PMID>
  </reference>
  <reference>
    <citation>Olitsky SE, Vilardo M, Awner S, Reynolds JD. Needle sterility during strabismus surgery. J AAPOS. 1998 Jun;2(3):151-2.</citation>
    <PMID>10532751</PMID>
  </reference>
  <reference>
    <citation>Prince HN, Nonemaker WS, Norgard RC, Prince DL. Drug resistance studies with topical antiseptics. J Pharm Sci. 1978 Nov;67(11):1629-31.</citation>
    <PMID>712607</PMID>
  </reference>
  <reference>
    <citation>Recchia FM, Baumal CR, Sivalingam A, Kleiner R, Duker JS, Vrabec TR. Endophthalmitis after pediatric strabismus surgery. Arch Ophthalmol. 2000 Jul;118(7):939-44.</citation>
    <PMID>10900107</PMID>
  </reference>
  <reference>
    <citation>Roberts SM, Severin GA, Lavach JD. Antibacterial activity of dilute povidone-iodine solutions used for ocular surface disinfection in dogs. Am J Vet Res. 1986 Jun;47(6):1207-10.</citation>
    <PMID>3729119</PMID>
  </reference>
  <reference>
    <citation>Singer TR, Isenberg SJ, Apt L. Conjunctival anaerobic and aerobic bacterial flora in paediatric versus adult subjects. Br J Ophthalmol. 1988 Jun;72(6):448-51.</citation>
    <PMID>3390421</PMID>
  </reference>
  <reference>
    <citation>Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 1991 May;98(5):639-49; discussion 650.</citation>
    <PMID>2062496</PMID>
  </reference>
  <reference>
    <citation>Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991 Dec;98(12):1769-75.</citation>
    <PMID>1775308</PMID>
  </reference>
  <reference>
    <citation>Zamora JL. Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions. Am J Surg. 1986 Mar;151(3):400-6. Review.</citation>
    <PMID>3513654</PMID>
  </reference>
  <reference>
    <citation>Zamora JL, Price MF, Chuang P, Gentry LO. Inhibition of povidone-iodine's bactericidal activity by common organic substances: an experimental study. Surgery. 1985 Jul;98(1):25-9.</citation>
    <PMID>4012604</PMID>
  </reference>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2007</study_first_submitted>
  <study_first_submitted_qc>April 17, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2007</study_first_posted>
  <last_update_submitted>March 4, 2013</last_update_submitted>
  <last_update_submitted_qc>March 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2013</last_update_posted>
  <responsible_party>
    <name_title>Prof. H.J. Simonsz M.D.</name_title>
    <organization>Erasmus Medical Center Rotterdam</organization>
  </responsible_party>
  <keyword>Antiseptic</keyword>
  <keyword>Povidone-Iodine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Strabismus</mesh_term>
    <mesh_term>Endophthalmitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iodine</mesh_term>
    <mesh_term>Povidone-Iodine</mesh_term>
    <mesh_term>Povidone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

